GGrantIndex
← Search

A MULTICENTER, OPEN-LABEL PHASE I/II STUDY TO EVALUATE SAFETY AND IMMUNOGENICITY

$21,581M01FY2008RRNIH

Indiana University Indianapolis, Indianapolis IN

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →